https://european-biotechnology.net/wp-content/uploads/2025/03/HDAC6-1030x643-1.jpg
643
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-25 07:45:082025-03-25 07:45:08Augustine Therapeutics NV raises €78m in Series A round
https://european-biotechnology.net/wp-content/uploads/2025/03/UK-ENgineering-Biotechnology_ARTMAXX-_1000_F_574160298_wtEFQHue2Zr7GAod2W61nRNn7ZaG7wbX.jpg
571
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-22 08:36:492025-03-22 08:36:49UK to boost scale-up of biomanufacturing infrastructure
https://european-biotechnology.net/wp-content/uploads/2025/03/DrenBio-e1742464407882-1030x580-1.png
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-21 05:08:432025-03-21 05:08:43Sanofi to acquire Dren Bio’s bispecific myeloid cell engager DR-201
https://european-biotechnology.net/wp-content/uploads/2025/03/Brainomix-e1742462502425-1030x581-1.png
581
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-20 09:57:582025-03-20 09:57:58Brainomix Ltd. completes £14m Series C financing
https://european-biotechnology.net/wp-content/uploads/2025/03/EB125_RETIKUS_tg-1030x427-1.jpg
427
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-18 15:07:222025-03-20 10:32:03US President deprioritises biotechnology
https://european-biotechnology.net/wp-content/uploads/2025/03/Sofinnova-partners_-DARIKA-1000_F_923962143_9P76yptBiAx0RlqF5Lxm7JJClXeuOjws.jpg
560
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-18 09:28:012025-03-18 09:28:01Sofinnova Partners closes €165m Biovelocita II biotech acceleration fund
https://european-biotechnology.net/wp-content/uploads/2025/03/EB125_Insight_Czeslaw-Siekierski_tg-1030x435-1.jpeg
435
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-17 10:27:522025-03-17 10:27:52Poland breaks opposition to EU NGT deregulation
https://european-biotechnology.net/wp-content/uploads/2025/03/SpliceBio-1030x465-1.jpg
465
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-14 09:32:332025-03-14 09:32:33SpliceBio lauches Phase I/II study on dual-AAV-based therapy for Stargardt Disease
https://european-biotechnology.net/wp-content/uploads/2025/03/FSA-1030x719-1.jpeg
719
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-12 11:50:152025-03-12 11:50:15Regulatory sandbox will speed up safety assessment of cell-based food
https://european-biotechnology.net/wp-content/uploads/2025/03/1000_F_1033449356_saD0ccutRtdFMXmfjDrcG2LSXgAG18TI.jpg
563
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-12 08:43:192025-03-12 08:43:19Roche inks US$1.65bn obesity deal with Zealand Pharma
Scroll to top
